Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

PURPOSE: We aimed to identify the differently expressed genes or related pathways associated with good responses to anti-HER2 therapy and to suggest a model for predicting drug response in neoadjuvant systemic therapy with trastuzumab in HER2-positive breast cancer patients. METHODS: This study was...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Ji Young, Park, Kyoung Hwa, Lee, Eun Sook, Kwon, Youngmee, Kim, Kyoung Tae, Nam, Seungyoon, Kim, Dong Hee, Bae, Jeoung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950611/
https://www.ncbi.nlm.nih.gov/pubmed/36814068
http://dx.doi.org/10.1177/10732748221141672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950611/
https://www.ncbi.nlm.nih.gov/pubmed/36814068
http://dx.doi.org/10.1177/10732748221141672

Ejemplares similares